AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Cassava SciencesCV SciencesCatabasis PharmaceuticalsCorvus PharmaceuticalsAVEO Pharmaceuticals
SymbolNASDAQ:SAVAOTCMKTS:CVSINASDAQ:CATBNASDAQ:CRVSNASDAQ:AVEO
Price Information
Current Price$2.14$0.88$6.21$3.66$8.16
52 Week RangeHoldBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.11.91.41.61.6
Analysis Score3.03.33.53.53.5
Community Score2.52.72.82.52.6
Dividend Score0.00.00.00.00.0
Ownership Score0.03.00.02.00.0
Earnings & Valuation Score0.00.60.60.01.9
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$14.00$3.35$45.00$7.75$20.00
% Upside from Price Target554.21% upside280.68% upside624.64% upside111.75% upside145.10% upside
Trade Information
Market Cap$51.54 million$87.87 million$116.17 million$102.30 million$121.73 million
Beta3.280.061.751.931.65
Average Volume2,931,669976,147177,676162,008408,855
Sales & Book Value
Annual RevenueN/A$53.70 million$500,000.00N/A$28.80 million
Price / SalesN/A1.64222.28N/A4.56
CashflowN/AN/AN/AN/A$0.54 per share
Price / CashN/AN/AN/AN/A15.06
Book Value$1.00 per share$0.25 per share$3.00 per share$2.15 per share$0.44 per share
Price / BookN/A3.522.07N/A18.55
Profitability
Net Income$-4,630,000.00$-16,610,000.00$-26,290,000.00$-46,670,000.00$9.39 million
EPS($0.27)($0.17)($2.35)($1.59)$0.61
Trailing P/E RatioN/AN/AN/AN/A13.38
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-26.31%N/AN/A1.62%
Return on Equity (ROE)-21.52%-40.55%-65.96%-63.69%4.28%
Return on Assets (ROA)-20.42%-23.71%-58.36%-54.35%0.95%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.36%0.02%0.03%0.52%
Current Ratio22.60%2.17%12.45%5.96%1.68%
Quick Ratio22.60%1.46%12.45%5.96%1.68%
Ownership Information
Institutional Ownership Percentage24.28%N/A33.61%73.90%28.10%
Insider Ownership Percentage13.70%14.60%3.20%45.12%4.20%
Miscellaneous
Employees978244917
Shares Outstanding24.78 million99.85 million17.90 million27.95 million16.08 million
Next Earnings Date8/10/2020 (Estimated)8/4/2020 (Estimated)8/13/2020 (Estimated)8/6/2020 (Estimated)8/13/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.